Marina Biotech, Inc. total revenue, net income and dynamics of changes in US dollar today
Marina Biotech, Inc. revenue for the past few reporting periods. The dynamics of Marina Biotech, Inc. net income went up. The change was 1 493 485 000 $. Net income, revenue and dynamics - the main financial indicators of Marina Biotech, Inc.. The financial report schedule from 31/03/2018 to 31/03/2021 is available online. Marina Biotech, Inc. financial report on the graph shows the dynamics of assets. A graph of the value of all Marina Biotech, Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
1 937 000 000 $
+11 987.360 % ↑
1 221 000 000 $
-
31/12/2020
570 745 000 $
+1 511.320 % ↑
-272 485 000 $
-
30/09/2020
157 910 000 $
+278.16 % ↑
-233 636 000 $
-
30/06/2020
66 351 000 $
-
-116 713 000 $
-
31/03/2019
16 025 000 $
-
-132 657 000 $
-
31/12/2018
35 421 000 $
-
-141 426 000 $
-
30/09/2018
41 757 000 $
-
-80 331 000 $
-
31/03/2018
29 039 000 $
-
-72 376 000 $
-
Show:
to
Marina Biotech, Inc. financial report charts
The latest dates of Marina Biotech, Inc. financial statements available online: 31/03/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Marina Biotech, Inc. for today is 31/03/2021. Gross profit Marina Biotech, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Marina Biotech, Inc. is 1 343 000 000 $
Marina Biotech, Inc. quarterly report dates
Cost of revenue Marina Biotech, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Marina Biotech, Inc. is 594 000 000 $ Total revenue Marina Biotech, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Marina Biotech, Inc. is 1 937 000 000 $ Operating income Marina Biotech, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Marina Biotech, Inc. is 1 266 000 000 $
Net income Marina Biotech, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Marina Biotech, Inc. is 1 221 000 000 $ Current assets Marina Biotech, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Marina Biotech, Inc. is 11 703 000 000 $ Total assets Marina Biotech, Inc. refers to the total amount of assets owned by a person or entity. Total assets Marina Biotech, Inc. is 12 694 000 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/03/2019
31/12/2018
30/09/2018
31/03/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 343 000 000 $
-196 048 000 $
-186 576 000 $
-85 505 000 $
-114 550 000 $
-115 008 000 $
-67 293 000 $
-61 085 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
594 000 000 $
766 793 000 $
344 486 000 $
151 856 000 $
130 575 000 $
150 429 000 $
109 050 000 $
90 124 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
1 937 000 000 $
570 745 000 $
157 910 000 $
66 351 000 $
16 025 000 $
35 421 000 $
41 757 000 $
29 039 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
16 025 000 $
35 421 000 $
41 757 000 $
29 039 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 266 000 000 $
-275 038 000 $
-235 117 000 $
-122 127 000 $
-141 833 000 $
-153 031 000 $
-85 818 000 $
-77 402 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 221 000 000 $
-272 485 000 $
-233 636 000 $
-116 713 000 $
-132 657 000 $
-141 426 000 $
-80 331 000 $
-72 376 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
671 000 000 $
845 783 000 $
393 027 000 $
188 478 000 $
157 858 000 $
188 452 000 $
127 575 000 $
106 441 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
11 703 000 000 $
6 297 879 000 $
3 577 211 000 $
2 796 744 000 $
1 140 827 000 $
1 563 006 000 $
1 117 947 000 $
-
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
12 694 000 000 $
7 336 750 000 $
4 650 873 000 $
3 486 006 000 $
1 806 207 000 $
1 962 149 000 $
1 489 160 000 $
-
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
5 442 000 000 $
2 623 850 000 $
1 505 581 000 $
1 761 629 000 $
502 934 000 $
658 364 000 $
167 060 000 $
-
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
159 159 000 $
222 803 000 $
186 418 000 $
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
360 174 000 $
431 908 000 $
412 728 000 $
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
19.94 %
22.01 %
27.72 %
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
3 838 000 000 $
2 561 375 000 $
2 759 798 000 $
2 946 885 000 $
1 446 033 000 $
1 530 241 000 $
-757 129 000 $
-551 365 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-143 927 000 $
-91 020 000 $
-81 958 000 $
-111 385 000 $
Last revenue report of Marina Biotech, Inc. was 31/03/2021. According to last financial report total revenue in Marina Biotech, Inc. was 1 937 000 000 US dollar and changed by +11 987.360% since last year. Net income in Marina Biotech, Inc. was 1 221 000 000 $ in last quartal, net income changes to 0%.
Current cash Marina Biotech, Inc. - the sum of all of the cash a company has on the date of report. Current cash Marina Biotech, Inc. is 5 442 000 000 $
Marina Biotech, Inc. stocks data
MRNA stock price
Marina Biotech, Inc. stock price today, MRNA stock quote.
